Package 50742-666-04

{"route": ["ORAL"], "spl_id": "5e9a2654-23e8-43de-a8fa-d981d7f13e40", "openfda": {"upc": ["0350742665167", "0350742665044", "0350742666041"], "unii": ["YQE403BP4D", "F2R8V82B84", "451IFR0GXB", "03J5ZE7KA5"], "rxcui": ["1046787"], "spl_set_id": ["33bf2df5-bc53-4d57-a9e7-41f3fc0a03f0"], "manufacturer_name": ["Ingenus Pharmaceuticals, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "118 mL in 1 BOTTLE (50742-666-04)", "package_ndc": "50742-666-04", "marketing_start_date": "20210801"}, {"sample": false, "description": "473 mL in 1 BOTTLE (50742-666-16)", "package_ndc": "50742-666-16", "marketing_start_date": "20210801"}], "brand_name": "Phenobarbital, Hyoscyamine Sulfate, Atropine Sulfate, Scopolamine Hydrobromide", "product_id": "50742-666_5e9a2654-23e8-43de-a8fa-d981d7f13e40", "dosage_form": "ELIXIR", "pharm_class": ["Anticholinergic [EPC]", "Anticholinergic [EPC]", "Cholinergic Antagonists [MoA]", "Cholinergic Antagonists [MoA]", "Cholinergic Muscarinic Antagonist [EPC]", "Cholinergic Muscarinic Antagonists [MoA]"], "product_ndc": "50742-666", "dea_schedule": "CIV", "generic_name": "Phenobarbital, Hyoscyamine Sulfate, Atropine Sulfate, Scopolamine Hydrobromide", "labeler_name": "Ingenus Pharmaceuticals, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Phenobarbital, Hyoscyamine Sulfate, Atropine Sulfate, Scopolamine Hydrobromide", "active_ingredients": [{"name": "ATROPINE SULFATE", "strength": ".0194 mg/5mL"}, {"name": "HYOSCYAMINE SULFATE", "strength": ".1037 mg/5mL"}, {"name": "PHENOBARBITAL", "strength": "16.2 mg/5mL"}, {"name": "SCOPOLAMINE HYDROBROMIDE", "strength": ".0065 mg/5mL"}], "marketing_category": "UNAPPROVED DRUG OTHER", "marketing_start_date": "20210801", "listing_expiration_date": "20261231"}